We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The lawyer for a former FBI agent told a jury that Vioxx caused his client's heart attack and the blockbuster drug's maker Merck & Co Inc. ignored danger signs from its withdrawn pain medicine as the second federal trial opened in New Orleans.
Shares of Biovail Corp. are down sharply Wednesday after a U.S. court granted Anchen Pharmaceuticals Inc. a key part of a summary judgment motion in the Wellbutrin XL patent infringement case.
Baum Hedlund filed a lawsuit against Philadelphia-based GlaxoSmithKline ("GSK"), the maker of Paxil, in Pennsylvania State Court, on behalf of its clients Anthony and Matilda Vasquez of Bedford, Texas, and their son Adrian.
Bayer AG has informed Schering AG that its takeover offer remains unchanged despite the recall of a Ultravist product and the disappointing sargramostim clinical trial results.
Novo Nordisk announced that the company filed a lawsuit against Pfizer claiming that Pfizer's product Exubera infringes on patents owned by Novo Nordisk.
Canadian drugmaker Apotex has been sued by Unigene Laboratories and Upsher-Smith Laboratories for allegedly infringing on the patent for their postmenopausal osteoporosis nasal spray Fortical.
A recent state supreme court decision to review the validity of a class action claim concerning Merck's drug Vioxx could raise the bar for a national case against the company, an industry attorney says.
The FDA's proposal to approve the controversial contraceptive Plan B for OTC use has inflamed critics of the agency, leading to a number of new questions about the agency's decisionmaking and the continuation of a threatened hold against Andrew von Eschenbach's nomination to be the FDA commissioner.